Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

A Study of MEK162 vs. Physician's Choice Chemotherapy in Patients With Low-grade Serous Ovarian, Fallopian Tube or Peritoneal Cancer

ClinicalTrials.gov ID: NCT01849874

Public ClinicalTrials.gov record NCT01849874. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 9:05 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

The MILO Study (MEK Inhibitor in Low-grade Serous Ovarian Cancer): A Multinational, Randomized, Open-label Phase 3 Study of MEK162 vs. Physician's Choice Chemotherapy in Patients With Recurrent or Persistent Low-grade Serous Carcinomas of the Ovary, Fallopian Tube or Primary Peritoneum

Study identification

NCT ID
NCT01849874
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
341 participants

Conditions and interventions

Interventions

  • MEK162, MEK inhibitor; oral Drug
  • Physician's choice chemotherapy Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 26, 2013
Primary completion
Jan 19, 2016
Completion
Aug 22, 2022
Last update posted
Oct 29, 2023

2013 – 2022

United States locations

U.S. sites
77
U.S. states
21
U.S. cities
40
Facility City State ZIP Site status
University of Arizona Cancer Center Phoenix Arizona 85004
Associated Retina Consultants, Ltd. Phoenix Arizona 85020
Oncology Research Associates, PLLC d/b/a Pinnacle Oncology Hematology Scottsdale Arizona 85258
Keck Hospital of USC Los Angeles California 90033
LAC & USC Medical Center Los Angeles California 90033
USC Healthcare Consultation Center 1 Los Angeles California 90033
USC Healthcare Consultation Center 2 Los Angeles California 90033
USC Norris Comprehensive Cancer Center Los Angeles California 90033
USC/Norris Comprehensive Cancer Center Los Angeles California 90033
Admin.Office/Study Supplies Mailing Address: UCLA Medicine Hematology-Oncology Los Angeles California 90095
Doris Stein Research Center Building Los Angeles California 90095
University of California Los Angeles, Hematology-Oncology Clinic Los Angeles California 90095
Gynecologic Oncology Associates Newport Beach California 92663
University of California, Irvine/UC Irvine Health Orange California 92868
UCLA Hematology/Oncology Clinic - Santa Monica Santa Monica California 90404
UCLA Hematology Oncology Clinic Santa Clarita Valencia California 91355
UCLA Hematology - Oncology Clinic - Westlake Village Westlake Village California 91361
Rocky Mountain Lions Eye Institute Aurora Colorado 80045
University of Colorado Cancer Center Aurora Colorado 80045
University of Colorado Denver, University of Colorado Cancer Center Aurora Colorado 80045
Smilow Cancer Hospital at Yale-New Haven New Haven Connecticut 06510
Eye Physicians of Central Florida Maitland Florida 32751
Florida Hospital Orlando Florida 32803
Florida Hospital Cancer Institute Orlando Florida 32804
Eye Physicians of Central Orlando Florida 32835
H. Lee Moffitt Cancer Center and Research Institute Tampa Florida 33612-9497
Florida Cancer Specialists Wellington Florida 33414
Florida Cancer Specialists West Palm Beach Florida 33401
Georgia Regents University Cancer Center Augusta Georgia 30912
University of Chicago Medical Center Chicago Illinois 60637
St. Vincent Cancer Care Indianapolis Indiana 46260
St. Vincent Gynecologic Oncology Indianapolis Indiana 46260
St. Vincent Gynecology Oncology Indianapolis Indiana 46260
St. Vincent Hospital and Health Care Center, Inc. Indianapolis Indiana 46260
Associated Vitreoretinal and Uveitis Consultants Indianapolis Indiana 46290
University of Iowa Hospitals and Clinics Iowa City Iowa 52242
University of Maryland Greenebaum Cancer Center Baltimore Maryland 21201
Massachusetts General Hospital Boston Massachusetts 02114
Ophthalmic Consultants of Boston (OCB) Boston Massachusetts 02114
Karmanos Cancer Institute Detroit Michigan 48201
Kresge Eye Institute Detroit Michigan 48201
Karmanos Cancer Institute Farmington Hills Michigan 48334
Barnes-Jewish Hospital St Louis Missouri 63110
Center for Advanced Medicine St Louis Missouri 63110
Center For Clinical Studies St Louis Missouri 63110
Washington University St Louis Missouri 63110
Billings Clinic Billings Montana 59101
University of New Mexico Cancer Center Albuquerque New Mexico 87106
Eye Associates of New Mexico Albuquerque New Mexico 87109
Memorial Sloan Kettering Cancer Center New York New York 10022
Montefiore Medical Center - Einstein Center for Cancer Care The Bronx New York 10461
Montefiore Medical Center The Bronx New York 10461
Montefiore Medical Center - Centennial Women's Health The Bronx New York 10467
Montefiore Medical Center, Green Medical Arts Pavilion The Bronx New York 10467
University of Cincinnati Medical Center Cincinnati Ohio 45219
Fairview Hospital Moll Pavilion Cancer Center Cleveland Ohio 44111
Cleveland Clinic Taussig Cancer Center Cleveland Ohio 44195
Cleveland Clinic-Main Campus Cleveland Ohio 44195
James Cancer Hospital & Solove Research Institute Columbus Ohio 43210
OSU Wexner Medical Center Columbus Ohio 43210
Stefanie Spielman Comprehensive Breast Cancer Columbus Ohio 43212
OSU Gynecologic Oncology at Mill Run Hilliard Ohio 43026
Hillcrest Hospital Mayfield Heights Ohio 44124
University of Cincinnati Physicians Company West Chester Ohio 45219
Dean McGee Eye Institute Oklahoma City Oklahoma 73104
Stephenson Cancer Center(clinic location) Oklahoma City Oklahoma 73104
Stephenson Cancer Center Oklahoma City Oklahoma 73104
Fox Chase Cancer Center Philadelphia Pennsylvania 19111
Jeanes Hospital Philadelphia Pennsylvania 19111
Magee-Womens Hospital of UPMC Pittsburgh Pennsylvania 15213
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213
Parkland Health and Hospital System Dallas Texas 75235
UT Southwestern Medical Center-Zale Lipshy University Hospital Dallas Texas 75235
UT Southwestern Medical Center-Clements University Hospital Dallas Texas 75390
UT Southwestern Medical Center Dallas Texas 75390
University of Texas MD Anderson Cancer Center Houston Texas 77030
University of Virginia Charlottesville Virginia 22903

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 149 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01849874, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 29, 2023 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01849874 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →